Noh, K. (2018). Integrin {beta}3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK-Rearranged NSCLC. The American Association for Cancer Research (AACR).
Chicago Style (17th ed.) CitationNoh, K.-W. Integrin {beta}3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK-Rearranged NSCLC. The American Association for Cancer Research (AACR), 2018.
MLA (9th ed.) CitationNoh, K.-W. Integrin {beta}3 Inhibition Enhances the Antitumor Activity of ALK Inhibitor in ALK-Rearranged NSCLC. The American Association for Cancer Research (AACR), 2018.
Warning: These citations may not always be 100% accurate.